Premium Content Editorial content

Dealmaking and differentiation in migraine’s big new market

After safety issues dashed hopes several years ago, calcitonin-gene related peptide has re-emerged as a prominent target, catalyzing deals and potentially reinvigorating the generic-dominated migraine market.

Please sign in or register for FREE

Register to BioPharma Dealmakers

From the publishers of Nature, the BioPharma Dealmakers website brings together life sciences companies and individuals looking to identify and attract partners and dealmaking opportunities. It provides insights into dealmaking trends from BioPharma Dealmakers Editors, profiles from companies looking to partner, tools for networking and sharing knowledge, and the opportunity for sponsoring companies to showcase their expertise. BioPharma Dealmakers is THE destination for partnering professionals looking to make connections and get the latest on their industry.


No comments yet.